TrianglePUBLICATIONS · 14604977
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2004 Mar 1
- First author
- Issa JP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Issa JP
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Giles FJ
- type
- Author
- name
- Mannari R
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Faderl S
- type
- Author
- name
- Bayar E
- type
- Author
- name
- Lyons J
- type
- Author
- name
- Rosenfeld CS
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Kantarjian HM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Issa JP
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Giles FJ
- type
- Author
- name
- Mannari R
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Faderl S
- type
- Author
- name
- Bayar E
- type
- Author
- name
- Lyons J
- type
- Author
- name
- Rosenfeld CS
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Kantarjian HM
- type
- Author
- bibliography ids
- nci-bib-30a86245c490dbf7373773a9
- book metadata
- content sha256
- fdd9e7522434a0712efb60fe951b554ab092800b4007e3073e2284800433f6e2
- document type
- citation
- dois
- 10.1182/blood-2003-03-0687
- electronic publication date
- display
- 2003 Nov 6
- precision
- day
- year
- 2003
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:14604977
- immutable id
- pubmed:14604977@fdd9e7522434a0712efb60fe951b554ab092800b4007e3073e2284800433f6e2
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 5
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1635-40
- volume
- 103
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 14604977
- provenance
- batch id
- aee154f17d1b0501fe1f
- provider
- NCBI PubMed ESummary
- record sha256
- e94d1a327e046fea4ae4a824f7cf89672b0e94fcdceab64158f44265c15fd358
- response sha256
- 75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
- retrieved at
- 2026-09-09T23:45:53.270896+00:00
- publication date
- display
- 2004 Mar 1
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Preserved source evidence · Not medical advice